Physician profile
Danielle Smith
NPI 1851762082
$5,353.75
in general payments reported to CMS, 2019-2025
18 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $607 · 2022: $2,911 · 2023: $1,210 · 2024: $509 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,835.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,710.84 | 2022-2023 | Reveal Linq |
| Abbott Laboratories | $790.91 | 2021-2023 | Aveir, Gallant |
| Kestra Medical Technology Services, INC. | $635.98 | 2023-2024 | Assure Wcd |
| Cvrx, INC. | $570.72 | 2021-2023 | Barostim Neo System |
| Boston Scientific Corporation | $268.52 | 2022 | |
| Biosense Webster, INC. | $241.10 | 2024-2025 | Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $206.18 | 2022-2024 | Lifevest |
| Amgen INC. | $205.61 | 2021-2023 | Repatha |
| Novo Nordisk INC | $117.00 | 2023 | |
| Cardiva Medical, INC. | $111.77 | 2021 | |
| Atricure, INC. | $100.91 | 2023 | |
| Merck Sharp & Dohme LLC | $97.04 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.81 | 2021 | |
| Merz North America, INC. | $86.80 | 2024 | |
| Abbvie INC. | $53.97 | 2023-2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $29.55 | 2021 | |
| Allergan, INC. | $22.04 | 2022 | |
| Mckesson Medical-Surgical, INC. | $15.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.